1. Home
  2. CELU vs POCI Comparison

CELU vs POCI Comparison

Compare CELU & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • POCI
  • Stock Information
  • Founded
  • CELU 2016
  • POCI 1982
  • Country
  • CELU United States
  • POCI United States
  • Employees
  • CELU N/A
  • POCI N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CELU Health Care
  • POCI Health Care
  • Exchange
  • CELU Nasdaq
  • POCI Nasdaq
  • Market Cap
  • CELU 37.7M
  • POCI 32.4M
  • IPO Year
  • CELU N/A
  • POCI N/A
  • Fundamental
  • Price
  • CELU $2.11
  • POCI $4.32
  • Analyst Decision
  • CELU
  • POCI
  • Analyst Count
  • CELU 0
  • POCI 0
  • Target Price
  • CELU N/A
  • POCI N/A
  • AVG Volume (30 Days)
  • CELU 91.2K
  • POCI 32.7K
  • Earning Date
  • CELU 05-08-2025
  • POCI 05-15-2025
  • Dividend Yield
  • CELU N/A
  • POCI N/A
  • EPS Growth
  • CELU N/A
  • POCI N/A
  • EPS
  • CELU N/A
  • POCI N/A
  • Revenue
  • CELU $54,220,000.00
  • POCI $17,626,155.00
  • Revenue This Year
  • CELU $23.29
  • POCI N/A
  • Revenue Next Year
  • CELU N/A
  • POCI N/A
  • P/E Ratio
  • CELU N/A
  • POCI N/A
  • Revenue Growth
  • CELU 138.11
  • POCI N/A
  • 52 Week Low
  • CELU $1.00
  • POCI $3.47
  • 52 Week High
  • CELU $5.22
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • CELU 54.10
  • POCI 47.11
  • Support Level
  • CELU $1.90
  • POCI $4.10
  • Resistance Level
  • CELU $2.47
  • POCI $4.68
  • Average True Range (ATR)
  • CELU 0.29
  • POCI 0.33
  • MACD
  • CELU 0.01
  • POCI -0.02
  • Stochastic Oscillator
  • CELU 58.25
  • POCI 28.30

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: